Cadila reports total income of Rs 16,041 million at Q4FY13
EBITDA margin is at 18.4 per cent A report compiled by Fortune, Cadila's total income at Rs 16,041 million grew by 15.3 per cent…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cipla posts Rs 19452 million income in Q4FY13
Adjusted PAT declines by 8.8 per cent primarily led by increase in tax rate and reduction in other income According to a report…
Indoco’s posts Rs 1604.8 million revenue during the fourth quarter of FY 2012-13
Profit after tax recorded at Rs 128.5 million
Sun Pharma posts net profit of Rs 1,011 crores during Q4 FY13
EBITDA margin reported at Rs 1,260 crores Sun Pharmaceutical Industries at its recently held board meeting in Mumbai has reported…
Pharma market posts double digit growth of 13.9 per cent in April 2013: IMS Health
Anti-diabetics was the fastest growing therapy for the month of April 2013
Goose launches ‘Quality Manager’ to help pharma industry prevent quality process…
The solution has been designed to offer real-time corrective measures to tackle deviation across product manufacturing life cycles…
A positive spin to clinical research
Industry is still frustrated by the recent policy changes but there is some hope that saner sense will ultimately prevail. Viveka…
Pharmexcil signs MoU with CCCMHPIE
To promote cooperation and trade between India and China for pharma and healthcare industries